Lucentis Prefilled Syringe


Lucentis ranibizumab injection is indicated for the treatment of neovascular (wet) age-related macular degeneration in adults; treatment of decreased visual acuity associated with diabetic macular edema following retinal vein occlusion (RVO) as monotherapy or in combination with laser coagulation in patients who have previously undergone laser coagulation,  diabetic retinopathy, etc.